Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 647,263 | 536,880 | 571,644 | 624,428 | 560,633 |
| Cost of Goods | 279,952 | 243,892 | 254,276 | 293,989 | 253,607 |
| Gross Profit | 367,311 | 292,988 | 317,368 | 330,439 | 307,026 |
| Operating Expenses | 258,663 | 242,138 | 243,271 | 272,223 | 250,173 |
| Operating Income | 109,600 | 51,742 | 74,373 | 59,205 | 57,460 |
| Interest Expense | 5,728 | 5,740 | 5,690 | 6,064 | 5,525 |
| Other Income | 1,580,589 | 1,199,943 | 830,016 | 646,289 | -387,151 |
| Pre-tax Income | 1,684,461 | 1,245,945 | 898,699 | 699,430 | -335,216 |
| Income Tax | 369,637 | 279,516 | 212,787 | 145,944 | -76,400 |
| Net Income Continuous | 1,314,824 | 966,429 | 685,912 | 553,486 | -258,816 |
| Net Income | $1,314,824 | $966,429 | $685,912 | $553,486 | $-258,816 |
| EPS Basic Total Ops | 44.24 | 32.59 | 22.97 | 18.50 | -8.68 |
| EPS Basic Continuous Ops | 44.24 | 32.59 | 22.97 | 18.49 | -8.68 |
| EPS Diluted Total Ops | 43.64 | 32.15 | 22.72 | 18.35 | -8.68 |
| EPS Diluted Continuous Ops | 43.64 | 32.15 | 22.72 | 18.34 | -8.68 |
| EBITDA(a) | $109,600 | $51,742 | $74,373 | $59,205 | $57,460 |